25 Jan, 2021 08:40 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today released its Appendix 4C for the consolidated group for the second quarter of FY 2021.
Highlights
End of peri...read more
25 Jan, 2021 08:21 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, advises that Mitsubishi Tanabe Pharma Singapore Pte Ltd (MTPS) have indicated their intention not to proceed with the Lice...read more
20 Jan, 2021 04:59 PM
To view the Notification of issue, conversion or payment up of equity +securities, download the attached PDF.
08 Jan, 2021 09:18 AM
Spacetalk Ltd. (ASX:SPA) (“Spacetalk” or “the Company”), developer of innovative technologies that keep families safe and connected, is pleased to provide the following updat...read more
05 Jan, 2021 11:00 AM
Spacetalk Ltd. (ASX:SPA) (“Spacetalk” or “the Company”), developer of innovative technologies that keep families safe and connected, will be showcasing a digital exhibition o...read more
30 Dec, 2020 04:09 PM
To view the Notification of issue, conversion or payment up of equity +securities, download the attached PDF.
23 Dec, 2020 01:49 PM
Spacetalk Ltd. (ASX:SPA) (“Spacetalk” or “the Company”), developer of innovative technologies that keep families safe and connected, plans to release a Business Update on Fri...read more
22 Dec, 2020 09:05 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, is pleased to announce the following letter to shareholders.
For the full document, please download the attached PDF.